


The Invesco Perpetual European Equity Income Fund aims to generate a rising level of income, together with long-term capital growth investing primarily into European equities, excluding the UK.
| Name | % Net Assets |
|---|---|
| Roche | 6.5% |
| Novartis | 6.1% |
| Nestle | 3.7% |
| Telefonica | 3.1% |
| Oesterreichische Post | 3.0% |
| Allianz | 2.5% |
| Delta Lloyd Nv Eur020 | 2.5% |
| Tryg | 2.4% |
| Repsol | 2.4% |
| Atlantia | 2.4% |
| Key | % Net Assets |
|---|---|
| 6.5% | |
| 6.1% | |
| 3.7% | |
| 3.1% | |
| 80.6% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 72.88p |
| Currency | GBP |
| Change | -0.060p |
| % | -0.08% |
| YTD change | 10.03p |
| YTD % | 15.96% |
| Fund Inception | 12/12/2007 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research